RNAi-mediated gene silencing of WDR5 or the inhibition of the N-MYC/WDR5 complex formation by a small molecule antagonist of WDR5 inhibits the expression of N-MYC target genes, which suppresses the growth of neuroblastoma cells [213]. The gene discussed is WDR5; the disease is neuroblastoma.